US$ 28.52
glp-1 and gip dual agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica glp 1 and gip dual
Description
Runge, S

The appetite suppression they produce is significant

Dungan, K

Pharmacological management of obesity: an Endocrine Society clinical practice guideline

Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/-catenin/NeuroD1 pathway

Register to Avail the Offer Send OTP By continuing, you agree with our Privacy Policy and Terms and Conditions Hi There, Sign up on PharmEasy now